Background: Antimicrobials essential for human health must be used judiciously. Objectives: Quantify current use and indications for critically important antibiotics (“protected antibiotics”) in general equine practice. Study Design: Prospective descriptive. Methods: Systemic use of 3 rd generation cephalosporins (ceftiofur), fluroquinolones (enrofloxacin and marbofloxacin), macrolides (clarithromycin), ansamycins (rifampin) and polymyxins (polymyxin B) (classified as “protected antibiotics”) were prospectively recorded in 19 equine practices over a six-month period (April - September 2023). Results: Protected antibiotics were prescribed to 200 horses with 10 horses prescribed two protected antibiotics concurrently. These included ceftiofur (48.2%), enrofloxacin (34.3%%), marbofloxacin (7.1%), polymyxin B (6.2%), rifampin (2.8%) and clarithromycin (1.4%). The mean number of protected antibiotics prescribed per practice was 10.5 (SD 12.4, range 0-41). The commonest clinical indications were respiratory disease (18.0%), foal septic diseases (16.5%), gastrointestinal diseases (15.0%), complicated wounds (13.5%), “dummy”/premature foals (7.5%) and cellulitis/lymphangitis (6.5%). Of 190 horses prescribed protected antibiotics, 76 (40.0%) were foals (less than 12 months of age). Horse age (foal or adult) was associated with specific antibiotic use (p < 0.001), with 73.7% of ceftiofur prescriptions for foals, and 97.0% and 100% of enrofloxacin and marbofloxacin prescriptions respectively for adults. Horses less than one year of age were less likely to have culture and antibiotic susceptibility testing (AST) compared to adults (P < 0.001). Commonest justifications for protected antibiotic use were lack of alternative preparations suitable for foals (27.5%), AST results (24.9%) and failure to respond to previous antibiotic treatment (17.1%). Main Limitations: Convenience sampling with small number of cases. Aminoglycoside use not evaluated. Conclusions: Respiratory and gastrointestinal diseases, complicated wounds and foal infections were the commonest reasons for protected antibiotic use. Lack of alternative drugs (for foals) and C&S results or failed previous treatments were commonest justifications.